PetVivo Holdings, Inc. (PETV) stock
PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.75+0.00 (0.00%)
Close on Oct 19, 2026Market cap $27.79MP/E –Yield –
PetVivo operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
PetVivo's operating cash flow for the twelve months ending Jun 30, 2026 was -$5.44M. For fiscal 2026 it was -$6.11M. The highest annual figure on record is -$49.34K in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$6.11M | – |
| FY2025 | Mar 31, 2025 | -$5.32M | – |
| FY2024 | Mar 31, 2024 | -$7.42M | – |
| FY2023 | Mar 31, 2023 | -$6.79M | – |
| FY2022 | Mar 31, 2022 | -$4.17M | – |
| FY2021 | Mar 31, 2021 | -$767.17K | – |
| FY2020 | Mar 31, 2020 | -$498.09K | – |
| FY2019 | Mar 31, 2019 | -$736.45K | – |
| FY2018 | Mar 31, 2018 | -$575.25K | – |
| FY2017 | Mar 31, 2017 | -$143.02K | – |
| FY2016 | Mar 31, 2016 | -$690.33K | – |
| FY2015 | Mar 31, 2015 | -$398.48K | – |
| FY2013 | Mar 31, 2013 | -$70.51K | – |
| FY2012 | Mar 31, 2012 | -$49.34K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$965.78K | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$812.38K | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$1.47M | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$2.19M | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$1.63M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$1.23M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$961.22K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$1.60M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$1.53M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$1.52M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$1.29M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$2.44M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$2.16M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$1.29M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$1.75M | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$2.05M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$1.70M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$1.65M | -17143.5% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$1.19M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$1.08M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$255.86K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $9.68K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$304.54K | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$236.98K | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$235.33K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$82.95K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$127.14K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$114.21K | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$173.80K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$139.35K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$160.81K | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$191.69K | -252.8% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$244.61K | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$329.40K | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$323.36K | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $125.48K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$47.97K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$55.06K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$4.01K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$32.71K | – |
See a number that looks wrong?